Treatment of patients with moderate asthma exacerbation that can be safely managed in the community.

Treatment of patients with an acute or sub-acute COPD exacerbation that can be safely managed in the community

Vaccination for people and whānau eligible for COVID-19 vaccination.

Treatment of children under 5 years with acute croup that can be safely managed in the community.

Treatment of patients with suspected DVT (excluding ACC) with a Wells Score of >= 2 or a positive D-dimer.

IV treatment for adults with moderate dehydration not responsive to oral fluids +/- antiemetic that can be safely managed in the community e.g. gastroenteritis, hyperemesis gravis, migraine. Oral rehydration only for children (6months - 15yrs) with moderate dehydration or at risk of getting severely dehydrated due to gastroenteritis that can be managed safely in the community.

Treatment of epistaxis that can be safely managed in the community.

Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.

Patients 65 years and over having an acute event, causing a borderline level of function with a reduction in personal activities of daily living or extended activities of daily living, meaning it is not safe to send them home.

This service aims to support and work with existing networks providing immunisation information, education, support and advice.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community. The infusion is to be provided in the community by the patient’s general practice

Administration of IV adenosine treatment for patients with rapid palpitations and a systolic BP >100.